Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves New Nasal Spray for Migraines

Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Lancet Neurology, The (Journal), Migraine Headaches, Nerves and Nervous System, Pfizer Inc
←RuPaul Shreds ‘Stunt Queen’ Politicians Pushing To Ban Drag Shows In Fiery Video
Michael Tilson Thomas Revels in the Present With the New York Phil→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube